Evidence map›Paper›PMID 29545785›Full record

ArticleFrontiers in microbiology2018

ArgR of

Alma Botas, Rosario Pérez-Redondo, Antonio Rodríguez-García, Rubén Álvarez-Álvarez, Paula Yagüe, Angel Manteca, Paloma Liras

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Gene expression reprogramming ofMicrobiology (Reading, England) · 2024
    Article
  5. Harnessing regulatory networks in Actinobacteria for natural product discovery.Journal of industrial microbiology & biotechnology · 2024
    Review
  6. Article
  7. Article
  8. Streptomyces clavuligerus: The Omics Era.Journal of industrial microbiology & biotechnology · 2021
    Article
  9. Article
  10. Article
  11. Review
  12. A Novel Two-Component System, Encoded by the sFrontiers in microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Alma BotasÁrea de Microbiología, Departamento de Biología Molecular, Universidad de León, León, Spain.
Rosario Pérez-RedondoInstituto de Biotecnología de León, León, Spain.
Antonio Rodríguez-GarcíaÁrea de Microbiología, Departamento de Biología Molecular, Universidad de León, León, Spain.
Rubén Álvarez-ÁlvarezÁrea de Microbiología, Departamento de Biología Molecular, Universidad de León, León, Spain.
Paula YagüeÁrea de Microbiología, Departamento de Biología Funcional e IUOPA, Universidad de Oviedo, Oviedo, Spain.
Angel MantecaÁrea de Microbiología, Departamento de Biología Funcional e IUOPA, Universidad de Oviedo, Oviedo, Spain.
Paloma LirasÁrea de Microbiología, Departamento de Biología Molecular, Universidad de León, León, Spain.
Universidad de León · ESInstituto de Biotecnología de León · ESUniversidad de Oviedo · ES

Funding

European Research Council 280304
6 · The paper itself

Abstract

ArgR is a well-characterized transcriptional repressor controlling the expression of arginine and pyrimidine biosynthetic genes in bacteria. In this work, the biological role of

Indexed as

antibioticsARG boxarginineArgRS. coelicolorsporulationtranscriptomics

Identifiers

PMID29545785
PMCPMC5839063
OpenAlexW2793866516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.